Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GUSB | P08236 | 2/20 | 0.38 |
| ▸ | EBP | Q15125 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.36 |
| ▸ | MGLL | Q99685 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.36 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.35 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.35 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | GALR3 | O60755 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL572164 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL2890409 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL899205 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL4066620 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL4066198 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL4061744 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL92757 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL372301 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL5305365 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL2219980 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3704757-B1 | ELECTROLYTE COMPOSITION | COMMW SCIENT IND RES ORG (AU) | 2025-07-09 | — | — | EP | claimed |
| CN-119615616-A | Ionic liquid impregnated modified antibacterial nylon fiber and preparation method thereof | 中国科学院过程工程研究所 | 2025-03-14 | — | — | CN | claimed |
| CN-119505228-A | Ionic liquid grafted modified high-temperature-resistant bio-based nylon and preparation method and application thereof | 中国科学院过程工程研究所 | 2025-02-25 | — | — | CN | claimed |
| EP-4470972-A1 | PROCESS FOR PRODUCING ONIUM SALTS OF BIS(FLUOROSULFONYL)IMIDE | SPECIALTY OPERATIONS FRANCE (FR) | 2024-12-04 | — | — | EP | claimed |
| CN-119059497-A | Process for the production of onium salts of bis (fluorosulfonyl) imide | 法国特种经营公司 | 2024-12-03 | — | — | CN | claimed |
| CN-118022788-A | Preparation method and application of biomass carbon coated heteropolyacid hydrogen salt catalyst | 西北大学 | 2024-05-14 | — | — | CN | claimed |
| CN-117984402-A | Glue-free self-adhesive type plate making material and preparation process thereof | 千年舟新材科技集团股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| WO-2024078801-A1 | CURABLE AND ELECTRICALLY DEBONDABLE ONE-COMPONENT (1K) STRUCTURAL ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2024-04-18 | — | — | WO | claimed |
| EP-4353760-A1 | CURABLE AND ELECTRICALLY DEBONDABLE ONE-COMPONENT (1K) STRUCTURAL ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2024-04-17 | — | — | EP | claimed |
| CN-117816238-A | Polyethylene nanofiber supported gold-ionic liquid catalyst for catalyzing hydrochlorination of acetylene as well as preparation and application thereof | 浙江工业大学 | 2024-04-05 | — | — | CN | claimed |
| WO-2006048171-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | claimed |
| WO-2006034239-A2 | ANTIMICROBIAL MESOPOROUS SILICA NANOPARTICLES | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2006-03-30 | — | — | WO | claimed |
| WO-2006029788-A1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-23 | — | — | WO | claimed |
| US-20060018966-A1 | Antimicrobial mesoporous silica nanoparticles | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2006-01-26 | — | — | US | claimed |
| CN-1609164-A | Process of preparing mesoporous molecular sieve with ionic liquid as template agent | UNIV EAST CHINA NORMAL (CN) | 2005-04-27 | — | — | CN | claimed |
| CN-1058694-C | Alkylation process | BP CHEM INT LTD (GB) | 2000-11-22 | — | — | CN | claimed |
| EP-0693045-B1 | ALKYLATION PROCESS | BP CHEM INT LTD (GB) | 1997-10-22 | — | — | EP | claimed |
| CN-1123023-A | Alkylation process | BP CHEM INT LTD (GB) | 1996-05-22 | — | — | CN | claimed |
| EP-0335115-B1 | PHARMACEUTICAL AND COSMETICAL COMPOSITIONS ON THE BASE OF BENZOYL PEROXIDE AND QUATERNARY AMMONIUM SALTS | L'OREAL (FR) | 1991-11-06 | — | — | EP | claimed |
| US-4960772-A | TREATING ACNE | L'OREAL (FR) | 1990-10-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018966-A1 | Antimicrobial mesoporous silica nanoparticles | MSN, SAAL1, MRPL21 | GUSB 4644/4885EBP 716/4885SIGMAR1 1106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.